How many patents does
Takeda have?
patents
1,458
families
112
granted
495
applications
963
US
185
EP
131
CN
80
JP
54
WO
42
KR
29
RoW
937
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Takeda
Top ten assignees appearing on patents
2009 - 2018
| nycomed | 564 |
| takeda | 504 |
| nycomed pharma | 77 |
| takeda nycomed | 72 |
| altana pharma | 50 |
| astrazeneca | 25 |
| takeda pharmaceutical company | 23 |
| amgen research (munich) | 18 |
| wyeth | 12 |
| nycomed asset management | 7 |
2009
| nycomed | 82 |
| nycomed pharma | 11 |
| altana pharma | 7 |
| wyeth | 4 |
| takeda | 3 |
| nicomede company | 1 |
| byk gulden lomberg chemische fabrik | 1 |
| autenna medicines | 1 |
| toshiba corporation | 1 |
| astrazeneca | 1 |
Takeda
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors | 61 | 2004 |
| combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the … 🛈 | 55 | 2006 |
| pyrazolone derivatives as pde4 inhibitors | 50 | 2007 |
| ophthalmological use of roflumilast for the treatment of diseases of the eye | 50 | 2002 |
| rolled collagen carrier | 49 | 2011 |
| oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrro… 🛈 | 40 | 2002 |
| 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4, 3-c] isoquinoline derivatives | 39 | 2009 |
| film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceut… 🛈 | 39 | 2005 |
| dosage form containing pantoprazole as active ingredient | 38 | 2003 |
| carrier with solid fibrinogen and solid thrombin | 34 | 2001 |